Skip to main content
. 2020 Jul 29;5(31):19721–19726. doi: 10.1021/acsomega.0c02421

Table 3. Interaction Results of Target Compounds with TMV-CPc.

compound 2 ribavirinb
Kda (μM) 12.6 ± 6.7 223.0 ± 66.2
EC50 (μg/mL) 84.8 ± 3.2 138.3 ± 4.2
a

Average of three replicates at 500 μg/mL.

b

Ribavirin was used as the control.

c

The ± values represent the standard deviation.